Novozymes upgrades guidance

Bioenergy division helps boost the Danish enzyme maker in everything from revenue to operations and profit, prompting the firm to raise its full-year guidance.

Photo: Novozymes/PR

Danish enzyme producer Novozymes presents its third-quarter fiscal report on Tuesday, revealing an upgrade to its guidance for the remaining year.

The company now eyes organic sales growth of 5-6 percent as well as an earnings margin before interest and taxes of around 27 percent. The previous expectation was for organic sales growth to reach 4-6 percent and the earnings margin to hit 26 percent.

Read the whole article

Get 14 days free access.
No credit card required.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from EnergyWatch

Further reading

Related articles

Latest News

See all jobs